GB Patent
GB0610866D0 — Novel in vivo imaging compounds
Assigned to Hammersmith Imanet Ltd · Expires 2006-07-12 · 20y expired
What this patent protects
Patent listed against Itovebi.
Drugs covered by this patent
- Itovebi (INAVOLISIB) · Genentech Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.